{Reference Type}: Journal Article
{Title}: The Impact of Independent Chemotherapy Prescribing by Advanced Practice Providers on Patient Safety and Clinician Satisfaction.
{Author}: LeStrange N;Walton A;Watson JL;Sklarin NT;Thompson JA;Affronti ML;
{Journal}: Clin J Oncol Nurs
{Volume}: 28
{Issue}: 4
{Year}: 2024 Jul 19
{Factor}: 1.283
{DOI}: 10.1188/24.CJON.397-405
{Abstract}: <B>BACKGROUND: </B>Literature on advanced practice providers (APPs) prescribing chemotherapy independently, without physician cosignature, is limited.<BR><B>OBJECTIVE: </B>This project assessed safety and provider satisfaction for an existing independent APP chemotherapy prescribing privilege at a National Cancer Institute-designated comprehensive cancer center.<BR><B>METHODS: </B>Rate of Reporting to Improve Safety and Quality events associated with APPs with independent chemotherapy prescribing privileges was compared to that of physicians during a three-year period. Satisfaction of APPs with independent chemotherapy prescribing privileges was evaluated.<BR><B>RESULTS: </B>The odds of a reported event were higher for physicians than for APPs. APP survey responses were positive for readiness, confidence, and satisfaction with independent chemotherapy prescribing privilege.